Pilot Biotechnology is an industrial biotechnology company engaged in the development, production, and sales of health care products.
Pilot Bio is a bio-manufacturing technology research and development company, focusing on bio-manufacturing of major chemical products, bio-process substitution in heavy-polluting industries, etc., providing users with bio-catalytic synthesis processes, enzyme product research and development, production, sales, and downstream companies with enzyme engineering , Technical service outsourcing and production service outsourcing of strain transformation and metabolic engineering.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Feb 8, 2022 | Series C | ¥100M | 1 | Lilly Asia Ventures | — | Detail |
Dec 16, 2021 | Series C | — | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Lilly Asia Ventures | Yes | Series C |
New Hope Sichuan Venture Capital Fund | — | Series C |